AlphaYouSA
Insider selling
Salomon Azoulay sold $2.7M of MBX Biosciences, Inc. (MBX) stock
Salomon Azoulay, Chief Medical Officer of MBX Biosciences, Inc. (MBX), sold 70,003 shares of MBX stock worth $2.7M, per an SEC Form 4 filed May 11, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 8, 2026, 3 days before it was made public.
MBX has moved +48.8% since the trade date, from $40.97 to $60.94 (Sep 21, 2026 close).
- Traded
- May 8, 2026
- Disclosed
- May 11, 2026
- Filing delay
- 3 days
- Price since
- +48.8%
- Role
- Chief Medical Officer
- Source
- SEC Form 4
More MBX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.